IM Cannabis Corp. (NASDAQ:IMCC) Short Interest Update
by Danessa Lincoln · The Markets DailyIM Cannabis Corp. (NASDAQ:IMCC – Get Free Report) was the target of a large growth in short interest during the month of September. As of September 15th, there was short interest totaling 45,409 shares, a growth of 262.1% from the August 31st total of 12,539 shares. Based on an average trading volume of 76,668 shares, the days-to-cover ratio is currently 0.6 days. Currently, 23.3% of the shares of the company are sold short.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of IM Cannabis in a research note on Tuesday, July 21st. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has an average rating of “Sell”.
View Our Latest Stock Report on IMCC
IM Cannabis Price Performance
Shares of NASDAQ:IMCC traded down $0.34 during trading on Friday, reaching $2.84. 590,544 shares of the company’s stock traded hands, compared to its average volume of 8,355,052. IM Cannabis has a 12 month low of $1.55 and a 12 month high of $77.10. The company has a 50 day moving average of $3.16 and a 200-day moving average of $7.46. The stock has a market capitalization of $596,400.00, a P/E ratio of -0.05 and a beta of 2.10.
IM Cannabis (NASDAQ:IMCC – Get Free Report) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.34) earnings per share for the quarter. IM Cannabis had a negative return on equity of 585.96% and a negative net margin of 39.62%.The business had revenue of $5.34 million for the quarter.
About IM Cannabis
IM Cannabis Corp. is a medical cannabis company that operates primarily in Israel and Germany. The company develops, imports, distributes and sells medical cannabis products through the IMC brand and related product lines.
Its product portfolio includes medical cannabis flower, oils and other cannabis-based products. In Israel, IM Cannabis serves the regulated medical cannabis market through activities that include product sourcing, distribution and sales to authorized patients and pharmacies.